SSI Strategy Expert Advisory Network (EAN)
About the EAN
SSI Strategy’s Expert Advisory Network connects biopharma teams with independent, conflict-checked drug development leaders – former CMOs, CEOs, and heads of development. Engagements are short and focused: scope the decision, curate the right leaders, and run a working session with clear next steps.
This curated network includes known quantities for SSI collaboration as we have worked or partnered with each member. We requested their participation as we share a similar mentality in partnership and delivery philosophy along with a proven shared track record. Collectively, we hold a passion to help our client partners achieve corporate objectives and advance therapeutic value.
Conflict-free, Independent Advisory. As external, conflict-checked advisors without sales agendas or staffing ties, we join for short, focused working sessions when a portfolio hinges on a choice, an IND needs a reset, or a story must land with investors. You get decisions, not decks—pragmatic calls from leaders who’ve done this before.
Who’s on the EAN
Usman 'Oz' Aazm
What we do together
Compliance & Independence
EAN advisors are external, non-salaried leaders. We run pre-engagement conflict checks, pay fair-market honoraria, and never sell or recruit through advisory work. This keeps guidance independent, practical, and focused on your decisions.
From The Emerging Biotech Leader
Balancing Current Needs and Long-Term Goals in Biotech : 31
Redefining Roles: From Medical Practice to Biotech Ventures : 32
Oral explanation – Your product’s last stand
LET’S TALK
You don't have to go it alone!
Our experienced team has been there before, and we're ready to guide you through the unknown. Share your challenges with us, and together, we'll create a plan to efficiently reach your milestones and turn your vision into reality.
Building Better Biotechs